These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33622635)

  • 1. Coronary bioresorbable vascular scaffolds: requiescant in pace?
    Alfonso F; Cuesta J; Rivero F
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):569-572. PubMed ID: 33622635
    [No Abstract]   [Full Text] [Related]  

  • 2. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous coronary intervention: balloons, stents and scaffolds.
    Colleran R; Kastrati A
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design Principles of Bioresorbable Polymeric Scaffolds.
    Kossuth MB; Perkins LEL; Rapoza RJ
    Interv Cardiol Clin; 2016 Jul; 5(3):349-355. PubMed ID: 28582032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longer look at trial evidence of bioresorbable vascular scaffolds.
    Brugaletta S; Sabate M
    Heart; 2017 Jul; 103(14):1061-1062. PubMed ID: 28232379
    [No Abstract]   [Full Text] [Related]  

  • 7. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
    Opolski MP; Kepka C; Wojakowski W; Witkowski A
    Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioresorbable Scaffolds for Coronary Artery Disease.
    Nathan A; Kobayashi T; Kolansky DM; Wilensky RL; Giri J
    Curr Cardiol Rep; 2017 Jan; 19(1):5. PubMed ID: 28108898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 11. Bailout left main bioresorbable vascular scaffolding for the treatment of iatrogenic coronary dissection induced by guiding catheter and sticky ABSORB bioresorbable vascular scaffold balloon.
    Yew KL
    Int J Cardiol; 2015; 187():527-9. PubMed ID: 25846666
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioresorbable Scaffold With Drug-Coated Balloon: A "Biodegradable" Model for Bifurcation Lesions Treatment. The New Intriguing Chapter of the "Leaving Nothing Behind" Saga.
    Buccheri D; Piraino D; Andolina G
    Am J Cardiol; 2016 Jul; 118(2):308-9. PubMed ID: 27206913
    [No Abstract]   [Full Text] [Related]  

  • 13. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
    Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
    [No Abstract]   [Full Text] [Related]  

  • 14. Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.
    Sorrentino S; Giustino G; Mehran R; Kini AS; Sharma SK; Faggioni M; Farhan S; Vogel B; Indolfi C; Dangas GD
    J Am Coll Cardiol; 2017 Jun; 69(25):3055-3066. PubMed ID: 28412389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioresorbable scaffolds: zebras are not striped horses.
    Tarantini G; Cardaioli F
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1084-1085. PubMed ID: 35441824
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombotic Left Main Coronary Artery Occlusion Treated With Bioresorbable Scaffold.
    Camacho Freire SJ; Gómez Menchero AE; Garrido JR; Rojas ML; Piris RC; Díaz Fernández JF
    Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 35797656
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention.
    Tenekecioglu E; Farooq V; Bourantas CV; Silva RC; Onuma Y; Yılmaz M; Serruys PW
    BMC Cardiovasc Disord; 2016 Feb; 16():38. PubMed ID: 26868826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
    Wiebe J; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revascularization treatment for spontaneous coronary artery dissection: A reconsideration of drug-coated balloons and bioresorbable vascular scaffold.
    Wu S; Liu W; Zhao Y; Shi D; Liu R; Wang J; Yu Y; Jia S; Sun Y; Zhou Y
    Int J Cardiol; 2016 Apr; 209():49-50. PubMed ID: 26878475
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of bioresorbable scaffolds: hype or hope?
    Tan HC; Ananthakrishna R
    Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.